Page last updated: 2024-08-24

telmisartan and Peritoneal Diseases

telmisartan has been researched along with Peritoneal Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gu, Y; Körbel, C; Laschke, MW; Menger, MD; Nenicu, A	1

Other Studies

1 other study(ies) available for telmisartan and Peritoneal Diseases

Article	Year
Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions. Human reproduction (Oxford, England), 2014, Volume: 29, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Down-Regulation; Endometriosis; Female; Gene Expression Profiling; Mice; Neovascularization, Pathologic; Peritoneal Diseases; Pioglitazone; PPAR gamma; Telmisartan; Thiazolidinediones; Up-Regulation	2014

Article

Year

Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.

Human reproduction (Oxford, England), 2014, Volume: 29, Issue:5

Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Down-Regulation; Endometriosis; Female; Gene Expression Profiling; Mice; Neovascularization, Pathologic; Peritoneal Diseases; Pioglitazone; PPAR gamma; Telmisartan; Thiazolidinediones; Up-Regulation

2014